Form 4: UnitedHealth Group Director Acquires Shares as Part of Compensation
SEC Form 4 Filing
A UnitedHealth Group director, John H. Noseworthy, acquired 186 shares of common stock as part of his quarterly compensation.
Summary
- John H. Noseworthy, a director at UnitedHealth Group, acquired 186 shares of common stock on January 2, 2025.
- These shares were granted as deferred stock units, which are part of his regular quarterly compensation for serving on the board.
- The deferred stock units are immediately vested, but the director must retain them until they complete their service on the board.
- The acquisition was made at a price of $0, indicating it was a grant rather than a purchase.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed positively as it aligns interests. There are no negative implications.
Positives
- The acquisition of shares aligns the director's interests with those of the shareholders.
- The grant of deferred stock units is a common practice for compensating board members.
Industry Context
This type of stock grant is a common practice for compensating board members in publicly traded companies, aligning their interests with those of shareholders.
Comparison to Industry Standards
- Many publicly traded companies use stock grants and deferred stock units as part of their compensation packages for board members.
- The practice of vesting shares immediately but requiring them to be held until the end of board service is also a common method to ensure long-term commitment from directors.
- Companies like Johnson & Johnson (JNJ) and Pfizer (PFE) also use similar compensation structures for their board members, often including a mix of cash and equity.
Stakeholder Impact
- The stock acquisition aligns the director's interests with those of the shareholders, which is generally positive for shareholders.
- The compensation structure is not expected to have a significant impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 01/02/2025 | Date of the stock acquisition by John H. Noseworthy. |
| 01/06/2025 | Date the Form 4 was signed by Faraz A. Choudhry, Attorney-in-Fact for John H. Noseworthy. |
Keywords
UnitedHealth Group, Director, Stock Acquisition, Deferred Stock Units, Compensation, UNH, Board of Directors
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.